PUMA BIOTECHNOLOGY INC (PBYI) stock analysis and AI prediction
The company facts of PUMA BIOTECHNOLOGY INC, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About PUMA BIOTECHNOLOGY INC
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $417.7 million
- Size
- Small cap
- Employees
- 179
- Headquarters
- LOS ANGELES, CA
- Listed since
- March 21, 2012
- Website
- pumabiotechnology.com
More Healthcare stocks
Other small cap stocks
Keep going
PBYI questions
What is the AI prediction for PBYI stock?
Each market day our model rates PUMA BIOTECHNOLOGY INC (PBYI) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the PBYI prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for PBYI?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see PBYI options?
The PBYI options page opens its calls and puts, with price, volume, implied volatility and the Greeks.